Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

Analytik Jena AG. (9/18/14). "Press Release: Executive Board and Supervisory Board of Analytik Jena AG Decide to Apply for the Delisting of the Analytik Jena Shares – Excercise of Call Options by the Majority Shareholder". Jena.

Organisations Organisation Analytik Jena AG
  Group Endress+Hauser (Group)
  Organisation 2 Thüringer Industriebeteiligungs-GmbH & Co. KG (TIB)
Product Product analytical instrument
Index term Index term Analytik Jena–Endress+Hauser: investment, 201409–201410 acquisition of addit 27.56% from Klaus Berka + TIB rasing share to 82.22%
Person Person Berka, Klaus (Analytik Jena 200702 Chairman Executive Board)
     


Ad Hoc Announcement in Accordance with Section 15 of the WpHG (German Securities Trading Act): Application for Delisting


The Supervisory Board of Analytik Jena AG today approved the resolution of the Executive Board to submit an application to the Frankfurt Stock Exchange to revoke the admission of its shares to the regulated market, including their current listing in the Prime Standard segment. The present listing of the shares for over-the-counter trading on the Stuttgart, Munich, Hanover, Düsseldorf, Berlin/Bremen, and Hamburg exchanges is not affected by this. The Company's majority shareholder, Endress+Hauser (Deutschland) AG & Co. KG, had announced immediately prior to the above mentioned resolution its intention to exercise call options in order to acquire the total of 2,109,633 shares (27.56 % of the share capital and voting rights) held by the two other major shareholders, Mr. Klaus Berka and the Thüringer Industriebeteiligungs-GmbH & Co. KG, in accordance with the option agreement concluded on November 14, 2013, on the condition that this would come into effect by 12:00 am on October 1, 2014, at the latest. Upon fulfillment of the condition, the majority shareholder's equity interest will amount to approximately 82.22 % of the Company's share capital and voting rights.

A significant reduction in the Company's administrative costs is expected from Analytik Jena AG's intended withdrawal from the regulated market. In the Executive Board's view, the Company's stock exchange listing no longer provides any significant benefits. In particular, the Company no longer relies on the possibility of raising capital on the stock exchange given the secured financing by its non-listed major shareholder Endress+Hauser (Deutschland) AG & Co. KG. The major shareholder already included a subsequent delisting as an intended step in its mandatory offer of October 31, 2013.

The protection of free-float investors is ensured not only by the shares' continued listing for over-the-counter trading, but also by the fact that the revocation of admission should not become effective immediately, but instead only after the maximum period of six months following its announcement by the management of the stock exchange, in accordance with section 46(2) sentence 3 of the BörsO (Stock Exchange Regulations) for the Frankfurt Stock Exchange. In the interests of protecting minority shareholders, the Executive Board and Supervisory Board have decided not to apply for any shortening of the six-month period in accordance with section 46(3) sentence 2 of the BörsO for the Frankfurt Stock Exchange.

   
Record changed: 2016-05-31

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Endress+Hauser (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px